Drawing for CHINOOK

USPTO serial 90083489

CHINOOK

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
SNAPP, TINA LOUISE
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with CHINOOK?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Maury M. Tepper, III

Maury M. Tepper, III Tepper & Eyster, PLLC3724 Benson DriveRaleigh, NC 27609United States

Goods and services

ClassDescriptionStatusFirst use
042Scientific research and development services; product research and development; pharmaceutical research and development; conducting clinical trials for others; providing a website featuring information in the field of medical and scientific research, product development, product testing in relation to prevention and treatment of kidney, renal, nephrological, glomerular, and urological diseases, disorders and conditions; provision of scientific research information in the field of prevention and treatment of kidney, renal, nephrological, glomerular, and urological diseases, disorders and conditions; providing a website featuring information in the field of medical and scientific research, product development and product testing; providing a website featuring information about investigational medical diagnostics and drugs; providing a website featuring educational information in the field of clinical research; providing medical and scientific research information in the field of clinical trials; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing information on the subject of scientific research in the field of biochemistry and biotechnology; providing medical and scientific research information in the field of pharmaceuticalsACTIVE—
044Providing information relating to the diagnostic and therapeutic properties of pharmaceutical preparations and biologic preparations for the prevention and treatment of diseases, disorders and conditions; providing a web site featuring medical information; providing medical information; providing health information; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; provision of information in the field of prevention and treatment of kidney, renal, nephrological, glomerular, and urological diseases, disorders and conditionsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Sep 16, 2024MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Sep 16, 2024ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Feb 22, 2024EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Feb 22, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 22, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 22, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Feb 13, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 12, 2024EX5GSOU EXTENSION 5 GRANTED—
Feb 12, 2024AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jan 31, 2024EXT5SOU EXTENSION 5 FILED—
Jan 31, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 8, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 6, 2023EX4GSOU EXTENSION 4 GRANTED—
Jul 6, 2023EXT4SOU EXTENSION 4 FILED—
Jul 6, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 2, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 31, 2023EX3GSOU EXTENSION 3 GRANTED—
Jan 31, 2023EXT3SOU EXTENSION 3 FILED—
Jan 31, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 3, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 1, 2022EX2GSOU EXTENSION 2 GRANTED—
Aug 1, 2022EXT2SOU EXTENSION 2 FILED—
Aug 1, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 20, 2022CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
May 20, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 20, 2022COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Feb 11, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 9, 2022EX1GSOU EXTENSION 1 GRANTED—
Feb 9, 2022EXT1SOU EXTENSION 1 FILED—
Feb 9, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 10, 2021NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 15, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 15, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 26, 2021ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
May 26, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 12, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 11, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 10, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 10, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 18, 2020GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 18, 2020GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 18, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 18, 2020DOCKASSIGNED TO EXAMINER—
Aug 28, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 3, 2020NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance